Published in Women's Health Weekly, September 22nd, 1997
Endometrial cancer is the most common gynecological cancer in the United States.
Jeffrey S. Ross, M.D., Oncor, Inc., Gaithersburg, Maryland, and colleagues at the Albany Medical College's Department of Pathology and Laboratory Medicine published the study results, which support the use of HER-2/neu gene amplification as a molecular marker in the evaluation of patients with endometrial cancer, in a recent issue of Molecular...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly